MENU
IBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
iBio (IBIO) Ownership - Who owns iBio?
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.64M
P/E Ratio
0.98
Total Cash
7.02M
Projected Growth
N/A
Total Debt
4M
Revenue
375K
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash/Share
0.71
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
IBIO
Capitalization
12.6M
P/E Ratio
0.98
Risk (Beta)
1.17
Dividend Yield
N/A
Total Cash
7.02M
Total Cash/Share
0.71
Total Debt
4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
375K
ROE
N/A
Book Value
13.9M
P/B Ratio
0.91
Cash Flow
N/A
Earnings
1.71
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
1.76
Current Revenue Per Employee
12500.00
Dividends Per Share - Security
N/A
EBITDA
-12.84M
Float
N/A
Float - Current
N/A
Gross Income Margin
75.41
Revenue To Assets
-69.29
Shares Held By Institutions
4.62M
Shares Outstanding - Current
9.88M
Total Liabilities
7.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-51.020
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the development and commercialization of vaccines and therapeutic proteins
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A